Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any autosomal dominant non-syndromic intellectual disability in which the cause of the disease is a mutation in the DOCK8 gene.
Features include always present findings: Delayed speech and language development, Global developmental delay, and Intellectual disability; and common findings: Prominent fingertip pads, Absent speech, Seizure, and Deeply set eye and others.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 5 | Delayed speech and language development, Absent speech, Seizure |
Biomarker and diagnostic research for intellectual disability, autosomal dominant 2 has been reported in the published literature.
Phenotype severity distribution: 3 always present features, 7 common features.
No clinical trials have been registered for intellectual disability, autosomal dominant 2.
120 publications have been identified in PubMed for intellectual disability, autosomal dominant 2. Research spans Case Report / Case Series (58%), Basic Science / Preclinical (14%), and Epidemiology / Natural History (10%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 62 | 58% |
Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 1:05 PM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Arms and legs |
1 |
Prominent fingertip pads |
Digestive system | 1 | Cholesteatoma |
Laboratory research
15 |
14% |
Disease patterns and progression | 11 | 10% |
Research summaries | 7 | 7% |
Clinical study results | 5 | 5% |
Testing and diagnosis research | 4 | 4% |
New treatment approaches | 2 | 2% |
Russell JK (2026). [PMID: 41709686](https://pubmed.ncbi.nlm.nih.gov/41709686/). *Current opinion in neurology*. [Review / Meta-Analysis]
Kostopoulou E (2026). [PMID: 42065018](https://pubmed.ncbi.nlm.nih.gov/42065018/). *Case Rep Neurol Med*. [Case Report / Case Series]
Zang H (2026). [PMID: 41853798](https://pubmed.ncbi.nlm.nih.gov/41853798/). *Experimental biology and medicine (Maywood, N.J.)*. [Basic Science / Preclinical]
Pan X (2026). [PMID: 41764152](https://pubmed.ncbi.nlm.nih.gov/41764152/). *Journal of molecular medicine (Berlin, Germany)*. [Case Report / Case Series]
Mammadova N (2026). [PMID: 42053849](https://pubmed.ncbi.nlm.nih.gov/42053849/). *Mol Biol Rep*. [Case Report / Case Series]
Romano F (2026). [PMID: 41344425](https://pubmed.ncbi.nlm.nih.gov/41344425/). *Eur J Med Genet*. [Case Report / Case Series]
Wang Z (2026). [PMID: 41916888](https://pubmed.ncbi.nlm.nih.gov/41916888/). *Zhonghua Yi Xue Yi Chuan Xue Za Zhi*. [Review / Meta-Analysis]
Yang Q (2026). [PMID: 41560868](https://pubmed.ncbi.nlm.nih.gov/41560868/). *Experimental and therapeutic medicine*. [Case Report / Case Series]
Chen H (2026). [PMID: 41656758](https://pubmed.ncbi.nlm.nih.gov/41656758/). *The Journal of international medical research*. [Case Report / Case Series]
Zhang Y (2026). [PMID: 41668056](https://pubmed.ncbi.nlm.nih.gov/41668056/). *BMC Oral Health*. [Case Report / Case Series]